Researchers found that higher methylation values of four genes (RASSF1A, CDH1, CDH13, and APC) were significantly associated with several traits of poorer outcome (tumor stage, growth pattern, muscle invasion, and tumor grade). Here, RASSF1 is linked to neoplasm.